Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the business would take into account new talks with insurers with regards to the checklist selling prices of Wegovy and copyright should they pledge to help keep the medicines on https://kethek.com/